ULS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
UL Solutions Inc (ULS) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. While the company has positive catalysts such as strong Q4 results, margin expansion, and a strategic acquisition, the financial performance shows declining net income and EPS, and the stock's short-term technical indicators suggest limited upside potential. It is advisable to hold off on buying until more favorable entry points or stronger growth signals emerge.
The technical indicators for ULS are mixed. The MACD is positive and expanding, indicating bullish momentum. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), and the stock is trading near its resistance level of 90.01. However, the RSI is at 70.001, which is neutral and does not provide a clear signal. The stock has a 50% chance of a slight decline (-0.55%) in the next day and limited upside potential (0.05%) in the next week.
UL Solutions delivered strong Q4 results with revenue, EBITDA margins, and EPS beating expectations.
The company is acquiring Eurofins Scientific's electrical and electronics business for €575 million, which could enhance its portfolio and long-term growth.
Margin expansion is supported by industrial tailwinds and elevated consumer activity.
Net income and EPS declined significantly in the latest quarter, down -17.28% and -17.50% YoY, respectively.
Analysts have mixed ratings, with several maintaining Neutral ratings and only a few projecting significant upside.
Near-term organic growth may moderate due to normalizing consumer demand, mixed software/advisory activity, and planned divestitures.
In Q4 2025, UL Solutions reported a 6.77% YoY increase in revenue to $789 million. However, net income dropped by -17.28% YoY to $67 million, and EPS declined by -17.50% YoY to $0.33. Gross margin improved by 4.90% YoY to 49.68%. While revenue growth is positive, declining profitability metrics are a concern.
Analyst ratings are mixed. BofA and Baird are optimistic, raising price targets to $96 and maintaining Buy/Outperform ratings. However, Citi, JPMorgan, and Goldman Sachs maintain Neutral ratings with modest price target increases. UBS also raised its price target to $90 but kept a Neutral rating. The consensus suggests limited upside in the near term.
